Olmesartan Plus Tablet 20/12.5 mg

Adult dose

In cases where blood pressure control is inadequate, administer 1 tablet once daily, irrespective of meals. The dosage should be adjusted every 2 to 4 weeks based on the patient's blood pressure response. Elderly patients should start at the lowest dose, and care should be taken to adjust the dose considering the patient's renal function, cardiac function, co-morbid conditions, and other medications.

Child dose

Safety and efficacy in pediatric patients have not been established.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to patients with known allergies to the components of this drug, those with certain kidney and liver diseases, pregnant or breastfeeding women, and patients with certain genetic metabolic disorders. Patients with low blood volume or sodium should be monitored closely when starting treatment as hypotension may occur initially. Use with caution in patients with impaired renal function, kidney transplant recipients, those with specific heart diseases, liver dysfunction, elderly individuals, and infants; regular blood tests to monitor renal function and electrolyte status should be performed if necessary. This medication can cause electrolyte imbalances, so if symptoms such as dry mouth, muscle cramps, or dizziness occur, medical consultation should be sought immediately. Blood pressure may drop significantly during treatment, so it is advisable to avoid high-altitude work or operating dangerous machinery. This medication may interact with various drugs; therefore, patients taking other medications must inform their healthcare provider, particularly when using potassium supplements, other antihypertensives, diuretics, lithium, or non-steroidal anti-inflammatory drugs. If breastfeeding, it is advisable to either stop breastfeeding or discontinue this medication as it may pass into breast milk and affect the infant. Safety and efficacy in pediatric patients have not yet been established, hence it is advisable not to use it in children. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur; appropriate treatment should be sought immediately. Rarely, side effects such as skin rash, headache, dizziness, gastrointestinal disturbances, blood abnormalities may occur; if symptoms persist or worsen, consult a healthcare provider.

Serious side effects

• Hives, severe swelling (edema), chest tightness, difficulty breathing, angioedema, anaphylaxis, severe allergic reaction
• Severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin adverse reactions
• Respiratory issues: acute respiratory distress syndrome (ARDS), pulmonary edema, interstitial pneumonia, asthma attacks
• Yellowing of skin or eyes (jaundice), hepatitis, acute cholecystitis, liver dysfunction, autoimmune issues

Mild side effects

• Headache
• dizziness
• nausea
• vomiting
• diarrhea
• indigestion
• abdominal pain
• fatigue
• drowsiness
• emotional blunting

Store this medication in a tightly closed container to protect it from air and moisture. The storage temperature should be suitable in a cool place between 1 and 25 degrees. This helps maintain the effectiveness of the medication for a longer period.

Appearance

Yellowish round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle